{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:40Z","timestamp":1776329800059,"version":"3.50.1"},"reference-count":9,"publisher":"Baskent University","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.6002\/ect.2024.0204","type":"journal-issue","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T02:51:18Z","timestamp":1732503078000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Miao Z, Zhang S, Ou X, et al. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020;221(10):1677-1687. doi:10.1093\/infdis\/jiz633","DOI":"10.1093\/infdis\/jiz633"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Wranke A, Heidrich B, Deterding K, et al. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection. Hepatol Int. 2023;17(6):1359-1367. doi:10.1007\/s12072-023-10575-0","DOI":"10.1007\/s12072-023-10575-0"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Abdrakhman A, Ashimkhanova A, Almawi WY. Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: a meta-analysis. Antiviral Res. 2021;185:104995. doi:10.1016\/j.antiviral.2020.104995","DOI":"10.1016\/j.antiviral.2020.104995"},{"key":"ref3","unstructured":"4. European Medicines Agency. Hepcludex. Published August 12, 2020. Updated September 28, 2023. https:\/\/www.ema.europa.eu\/en\/ medicines\/human\/EPAR\/hepcludex"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Lampertico P, Roulot D, Wedemeyer H. Bulevirtide with or without pegIFN\u03b1 for patients with compensated chronic hepatitis delta: from clinical trials to real-world studies. J Hepatol. 2022;77(5):1422-1430. doi:10.1016\/j.jhep.2022.06.010","DOI":"10.1016\/j.jhep.2022.06.010"},{"key":"ref5","unstructured":"6. Liverpool Drug Interactions Group. HEP Drug Interaction Checker. University of Liverpool. Accessed January 8, 2024. https:\/\/hep-druginteractions.org\/checker"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Wedemeyer H, Aleman S, Brunetto M, et al. Bulevirtide monotherapy in patients with chronic HDV: efficacy and safety results through week 96 from a phase III randomized trial. J Hepatol. 2024;81(4):621-629. doi:10.1016\/j.jhep.2024.05.001","DOI":"10.1016\/j.jhep.2024.05.001"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Wedemeyer H, Aleman S, Andreone P et al. Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24-week interim data of the phase 3 MYR301 study. J Hepatol. 2021;75(Suppl 2):S294-S295. LBP-2730. doi:10.1016\/S0168-8278(21)01843-2","DOI":"10.1016\/S0168-8278(21)01843-2"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Zhu V, Burhenne J, Weiss J et al. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Front Pharmacol. 2023;14:1128547. doi:10.3389\/fphar.2023.1128547","DOI":"10.3389\/fphar.2023.1128547"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T03:21:42Z","timestamp":1732504902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2024\/22\/10\/0\/810\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2024.0204","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}